Nanobiotix S.A.
IPOBuilding new cancer therapies atom by atom | Nanobiotix
Public · Paris, France · $14.6M raised
- Headquarters
- Paris
- Employees
- 51–200
- Business Model
- B2B
- Website
- nanobiotix.com
- Total Funding
- $14.6M
- Last Round
- $4.8M Corporate RoundDec 2023
- Rounds
- 3
- Type
- Public
About
French clinical-stage nanotech company developing hafnium oxide nanoparticle NBTXR3 to amplify radiotherapy effects in cancer tumors.
Summary
Nanobiotix S.A. is a Biotech company based in Paris, France. It has raised $14.6M in total across 3 rounds, most recently a $4.8M Corporate Round round in Dec 2023. Investors include Johnson & Johnson Innovation - JJDC.
Tech & App Stack
6 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Dec 2023
Sign up to see all 6 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...